FolioLanternBeta
ODTXOdyssey Therapeutics, Inc.

Jason Haas

Chief Financial Officer at Odyssey Therapeutics, Inc., as of May 11, 2026In the past 12 months: bought $20K of stock in 1 open-market purchase.

Updated Oct 13, 2026 from SEC filings · covers Oct 14, 2025 to Oct 13, 2026
$20K
open-market purchases, past 12 months (1 trade)
1
company filed for

Shares held at Odyssey Therapeutics, Inc. is being verified and not shown yet. Why

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Odyssey Therapeutics, Inc. (ODTX)Chief Financial OfficerMay 7, 2026May 11, 2026

Recent filings

The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.